TORONTO DOMINION BANK – Regeneron Pharmaceuticals, Inc. Transaction History
TORONTO DOMINION BANK portfolio value:
$32.58M
portfolio value
TORONTO DOMINION BANK quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -14.85% | -8.25K shares | -260K | $688.87 | 47.31K |
| Q2 2022 | share | Decrease | -12.43% | -7.88K shares | -11.47M | $591.13 | 55.56K |
| Q1 2022 | share | Decrease | -12.04% | -8.68K shares | -1.24M | $698.42 | 63.45K |
| Q4 2021 | share | Increase | +25.58% | 14.69K shares | 10.79M | $642.51 | 72.14K |
| Q3 2021 | share | Increase | +24.21% | 11.19K shares | 8.93M | $605.18 | 57.44K |
| Q2 2021 | share | Decrease | -10.31% | -5.31K shares | 1.43M | $558.54 | 46.25K |
| Q1 2021 | share | Decrease | -16.34% | -10.07K shares | -5.38M | $473.14 | 51.56K |
| Q4 2020 | share | Increase | +5.25% | 3.07K shares | -3.00M | $483.11 | 61.64K |
| Q3 2020 | share | Decrease | -11.86% | -7.87K shares | -8.65M | $559.78 | 58.57K |
| Q2 2020 | share | Increase | +9.47% | 5.74K shares | 11.80M | $623.65 | 66.44K |
| Q1 2020 | share | Decrease | -44.06% | -47.80K shares | -11.09M | $488.29 | 60.70K |
| Q4 2019 | share | Increase | +39.08% | 30.48K shares | 19.09M | $375.48 | 108.50K |
| Q3 2019 | share | Increase | +34.01% | 19.79K shares | 3.42M | $277.4 | 78.01K |
| Q2 2019 | share | Decrease | -9.83% | -6.34K shares | -8.28M | $313 | 58.21K |
| Q1 2019 | share | Increase | +37.77% | 17.69K shares | 9.00M | $410.62 | 64.55K |
| Q4 2018 | share | Decrease | -7.76% | -3.94K shares | -3.02M | $373.5 | 46.86K |
| Q3 2018 | share | Increase | +1.78% | 889 shares | 3.30M | $404.04 | 50.80K |
| Q2 2018 | share | Increase | +19.53% | 8.15K shares | 2.84M | $344.99 | 49.91K |
| Q1 2018 | share | Increase | +25.56% | 8.5K shares | 1.87M | $344.36 | 41.75K |
| Q4 2017 | share | Increase | +13.89% | 4.05K shares | -551K | $375.96 | 33.25K |
| Q3 2017 | share | Increase | +13.03% | 3.36K shares | 369K | $447.12 | 29.20K |
| Q2 2017 | share | Increase | +25.78% | 5.29K shares | 4.72M | $491.14 | 25.83K |
| Q1 2017 | share | Increase | +57.36% | 7.48K shares | 3.16M | $387.51 | 20.54K |
| Q4 2016 | share | Increase | +487.71% | 10.83K shares | 3.89M | $367.09 | 13.05K |
| Q3 2016 | share | Increase | +423.82% | 1.79K shares | 745K | $402.02 | 2.22K |
| Q2 2016 | share | Decrease | -26.39% | -152 shares | -60K | $349.23 | 424 |
| Q1 2016 | share | Decrease | -75.80% | -1.80K shares | -1.08M | $360.44 | 576 |